BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11718265)

  • 1. The properties of solid Zn(II)-amino acid complexes in the form of suspensions.
    Dolińska B
    Farmaco; 2001 Oct; 56(10):737-40. PubMed ID: 11718265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of physicochemical properties of amino acid on their release from the Zn(II)-amino acid complexes in suspension.
    Dolińska B; Ryszka F
    Boll Chim Farm; 2002; 141(3):218-22. PubMed ID: 12197421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and properties of selected Zn(II)-peptide complexes in suspension.
    Dolińska B; Ryszka F
    Farmaco; 2003 Nov; 58(11):1131-6. PubMed ID: 14572864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of slightly soluble Zn(II)-protein complexes in the form of a suspension.
    Dolińska B; Ryszka F
    Farmaco; 2005 Jan; 60(1):71-5. PubMed ID: 15652372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of selected amino acids from zinc carriers.
    Dyja R; Dolińska B; Ryszka F
    Acta Pharm; 2016 Jun; 66(2):269-77. PubMed ID: 27279069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile and sustained peptides release from Zn(II) suspensions.
    Ryszka F; Dolinska B
    Boll Chim Farm; 2003 Oct; 142(8):319-23. PubMed ID: 15040459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid and peptide bioconjugates of copper(II) and zinc(II) complexes with a modified N,N-bis(2-picolyl)amine ligand.
    Kirin SI; Dübon P; Weyhermüller T; Bill E; Metzler-Nolte N
    Inorg Chem; 2005 Jul; 44(15):5405-15. PubMed ID: 16022539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies.
    Kubíček V; Böhmová Z; Ševčíková R; Vaněk J; Lubal P; Poláková Z; Michalicová R; Kotek J; Hermann P
    Inorg Chem; 2018 Mar; 57(6):3061-3072. PubMed ID: 29488748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc site redesign in T4 gene 32 protein: structure and stability of cobalt(II) complexes formed by wild-type and metal ligand substitution mutants.
    Guo J; Giedroc DP
    Biochemistry; 1997 Jan; 36(4):730-42. PubMed ID: 9020770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-field solid-state (67)Zn NMR spectroscopy of several zinc-amino acid complexes.
    Mroué KH; Power WP
    J Phys Chem A; 2010 Jan; 114(1):324-35. PubMed ID: 19919076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dinuclear zinc(II) complexes of tetraiminodiphenol macrocycles and their interactions with carboxylate anions and amino acids. Photoluminescence, equilibria, and structure.
    Dutta B; Bag P; Flörke U; Nag K
    Inorg Chem; 2005 Jan; 44(1):147-57. PubMed ID: 15627370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deducing the energetic cost of protein folding in zinc finger proteins using designed metallopeptides.
    Reddi AR; Guzman TR; Breece RM; Tierney DL; Gibney BR
    J Am Chem Soc; 2007 Oct; 129(42):12815-27. PubMed ID: 17902663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-branched chiral (racemic) macrocyclic amino acids: structure of their Ni(II), Zn(II) and Cu(II) complexes.
    Pellico D; Gómez-Gallego M; Escudero R; Ramírez-López P; Oliván M; Sierra MA
    Dalton Trans; 2011 Sep; 40(36):9145-53. PubMed ID: 21822522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femtomolar Zn(II) affinity in a peptide-based ligand designed to model thiolate-rich metalloprotein active sites.
    Petros AK; Reddi AR; Kennedy ML; Hyslop AG; Gibney BR
    Inorg Chem; 2006 Dec; 45(25):9941-58. PubMed ID: 17140191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vibrational spectra of Zn(II) complexes of the amino acids with hydrophobic residues.
    Wagner CC; Baran EJ
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jun; 72(5):936-40. PubMed ID: 19186099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zn(II) binding and DNA binding properties of ligand-substituted CXHH-type zinc finger proteins.
    Imanishi M; Matsumura K; Tsuji S; Nakaya T; Negi S; Futaki S; Sugiura Y
    Biochemistry; 2012 Apr; 51(16):3342-8. PubMed ID: 22482427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
    Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
    J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexation equilibria and coordination aspects of Zn(II) complexes contain 2-aminobenzamide and some bioactive amino acid mixed ligands: pH-metric, spectroscopic and thermodynamic studies.
    Dharmaraja J; Subbaraj P; Esakkidurai T; Shobana S; Raji S
    Acta Chim Slov; 2014; 61(4):803-12. PubMed ID: 25551720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Stability Constants of Zinc(II) Complexes with 2-aminobenzamide and Amino Acids.
    Miličević A; Raos N
    Acta Chim Slov; 2015; 62(4):784-8. PubMed ID: 26680705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.